MedAdvisor Limited (MDR.AX)
AUD 0.09
(-1.05%)
AUD 0.09
(-1.05%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 122.1 Million AUD | 24.64% |
| 2023 | 97.96 Million AUD | 44.6% |
| 2022 | 67.75 Million AUD | 74.74% |
| 2021 | 38.77 Million AUD | 303.77% |
| 2020 | 9.6 Million AUD | 16.51% |
| 2019 | 8.24 Million AUD | 24.79% |
| 2018 | 6.6 Million AUD | 55.67% |
| 2017 | 4.24 Million AUD | 197.57% |
| 2016 | 1.42 Million AUD | -13.36% |
| 2015 | 1.64 Million AUD | 54.49% |
| 2014 | 1.06 Million AUD | 24.28% |
| 2013 | 857.14 Thousand AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 122.1 Million AUD | 24.64% |
| 2024 Q4 | 46.55 Million AUD | 0.0% |
| 2024 Q2 | 75.54 Million AUD | 0.0% |
| 2023 Q2 | 64.08 Million AUD | 0.0% |
| 2023 FY | 97.96 Million AUD | 44.6% |
| 2023 Q4 | 33.88 Million AUD | 0.0% |
| 2022 FY | 67.75 Million AUD | 74.74% |
| 2022 Q2 | 38.65 Million AUD | 0.0% |
| 2022 Q4 | 29.09 Million AUD | 0.0% |
| 2021 FY | 38.77 Million AUD | 303.77% |
| 2021 Q4 | 25.85 Million AUD | 0.0% |
| 2021 Q2 | 12.91 Million AUD | 0.0% |
| 2020 FY | 9.6 Million AUD | 16.51% |
| 2020 Q4 | 5.15 Million AUD | 0.0% |
| 2020 Q2 | 4.44 Million AUD | 0.0% |
| 2019 Q2 | 3.88 Million AUD | 0.0% |
| 2019 FY | 8.24 Million AUD | 24.79% |
| 2019 Q4 | 4.35 Million AUD | 0.0% |
| 2018 Q2 | 3.25 Million AUD | 0.0% |
| 2018 FY | 6.6 Million AUD | 55.67% |
| 2018 Q4 | 3.34 Million AUD | 0.0% |
| 2017 Q2 | 1.54 Million AUD | 0.0% |
| 2017 FY | 4.24 Million AUD | 197.57% |
| 2017 Q4 | 2.69 Million AUD | 0.0% |
| 2016 FY | 1.42 Million AUD | -13.36% |
| 2016 Q2 | 679.74 Thousand AUD | 0.0% |
| 2016 Q4 | 746.04 Thousand AUD | 0.0% |
| 2015 FY | 1.64 Million AUD | 54.49% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 Q4 | 846.09 Thousand AUD | 0.0% |
| 2015 Q2 | 799.62 Thousand AUD | 0.0% |
| 2014 Q3 | - AUD | 0.0% |
| 2014 FY | 1.06 Million AUD | 24.28% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 FY | 857.14 Thousand AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q1 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alcidion Group Limited | 37.05 Million AUD | -229.508% |
| Artrya Limited | - AUD | -Infinity% |
| Beamtree Holdings Limited | 27.6 Million AUD | -342.396% |
| Cogstate Limited | 66.27 Million AUD | -84.247% |
| Careteq Limited | 7.23 Million AUD | -1588.548% |
| Doctor Care Anywhere Group PLC | 72.02 Million AUD | -69.524% |
| Emyria Limited | 2.2 Million AUD | -5443.416% |
| Global Health Limited | 8.12 Million AUD | -1403.262% |
| HITIQ Limited | 4.74 Million AUD | -2471.255% |
| Intelicare Holdings Limited | 280.29 Thousand AUD | -43463.772% |
| ImExHS Limited | 19.66 Million AUD | -520.802% |
| Mach7 Technologies Limited | 29.12 Million AUD | -319.232% |
| Oakridge International Limited | 814.73 Thousand AUD | -14887.231% |
| Opyl Limited | 397.63 Thousand AUD | -30607.848% |
| PainChek Limited | 2.67 Million AUD | -4469.933% |
| Pro Medicus Limited | 161.5 Million AUD | 24.393% |
| Resonance Health Limited | 8.58 Million AUD | -1321.572% |
| Singular Health Group Ltd | 90.82 Thousand AUD | -134340.701% |
| Total Brain Limited | 8.41 Million AUD | -1350.947% |